Log In
BCIQ
Print this Print this
 

Interleukin-2 (IL-2) receptor alpha chain (CD25)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Interleukin-2 (IL-2) receptor alpha chain (CD25)

BCIQ
Print ChartPrint this
0 0 1 1 0 0 0 1 0
Phases of DevelopmentINDRegistrationMarketed
Autoimmune

0

1

0

Cancer

1

0

0

Transplant

0

0

1




 Products Targeting Interleukin-2 (IL-2) receptor alpha chain (CD25)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$1,171.9M

$1,171.9M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today